Clinical trials
Observational Anemia, Refractory, with Excess of Blasts trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2004 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2020 | 3 |
| 2022 | 2 |
| 2024 | 1 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Unknown status | 5 |
| Not yet recruiting | 3 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
| Terminated | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fondazione Italiana Sindromi Mielodisplastiche-ETS | 4 |
| University of California, San Francisco | 3 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| ARCE Therapeutics, Inc. | 1 |
| Alliance for Clinical Trials in Oncology | 1 |
| Beth Israel Medical Center | 1 |
| CareDx | 1 |
| Center for International Blood and Marrow Transplant Research | 1 |
| Children's Oncology Group | 1 |
| Duke University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Refractory, with Excess of Blasts | 26 |
| Leukemia, Myeloid, Acute | 11 |
| Hematologic Neoplasms | 4 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 4 |
| Lymphoma | 4 |
| Neoplasms, Plasma Cell | 4 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Anemia, Aplastic | 3 |
| Leukemia | 3 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
Trials
Showing 51 to 26 of 26. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.